Skip to main content

Table 4 Six months clinical follow-up

From: Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent

 

BVS (n = 26)

EES (n = 34)

P-value

MACE, n (%)

1 (4)

2 (6)

1.000

Death, n (%)

0

0

 

MI, n (%)

0

0

 

TV-Revasc., n (%)

1 (4)

2 (6)

1.000

Non-TV-Revasc. n (%)

0

0

 
  1. MACE Major Adverse Cardiac Event, MI Myocardial Infarction, TV Target Vessel, Revasc - Revascularization
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us